IRIS Accounts Production v25.1.4.42 14000167 Board of Directors 1.10.23 30.9.24 30.9.24 Medium entities a holding company. true true false true true false false true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh140001672023-09-30140001672024-09-30140001672023-10-012024-09-30140001672022-09-30140001672022-10-012023-09-30140001672023-09-3014000167ns15:EnglandWales2023-10-012024-09-3014000167ns14:PoundSterling2023-10-012024-09-3014000167ns10:Director12023-10-012024-09-3014000167ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3014000167ns10:MediumEntities2023-10-012024-09-3014000167ns10:Audited2023-10-012024-09-3014000167ns10:Medium-sizedCompaniesRegimeForDirectorsReport2023-10-012024-09-3014000167ns10:Medium-sizedCompaniesRegimeForAccounts2023-10-012024-09-3014000167ns10:FullAccounts2023-10-012024-09-3014000167ns10:OrdinaryShareClass12023-10-012024-09-3014000167ns10:OrdinaryShareClass22023-10-012024-09-3014000167ns10:OrdinaryShareClass32023-10-012024-09-3014000167ns10:Director22023-10-012024-09-3014000167ns10:Director32023-10-012024-09-3014000167ns10:RegisteredOffice2023-10-012024-09-3014000167ns5:CurrentFinancialInstruments2024-09-3014000167ns5:CurrentFinancialInstruments2023-09-3014000167ns5:ShareCapital2024-09-3014000167ns5:ShareCapital2023-09-3014000167ns5:ShareCapital2022-09-3014000167ns5:RetainedEarningsAccumulatedLosses2022-09-3014000167ns5:RetainedEarningsAccumulatedLosses2022-10-012023-09-3014000167ns5:RetainedEarningsAccumulatedLosses2023-09-3014000167ns5:RetainedEarningsAccumulatedLosses2023-10-012024-09-3014000167ns5:RetainedEarningsAccumulatedLosses2024-09-3014000167ns10:OrdinaryShareClass12022-10-012023-09-3014000167ns5:CostValuation2023-09-3014000167ns5:Subsidiary12023-10-012024-09-30140001671ns5:Subsidiary12023-10-012024-09-3014000167ns5:Subsidiary12024-09-3014000167ns5:Subsidiary12023-09-3014000167ns5:Subsidiary12022-10-012023-09-3014000167ns5:Subsidiary22023-10-012024-09-3014000167ns5:Subsidiary232023-10-012024-09-3014000167ns5:Subsidiary22024-09-3014000167ns5:Subsidiary22023-09-3014000167ns5:Subsidiary22022-10-012023-09-3014000167ns5:Subsidiary32023-10-012024-09-30140001675ns5:Subsidiary32023-10-012024-09-3014000167ns5:Subsidiary32024-09-3014000167ns5:Subsidiary32023-09-3014000167ns5:Subsidiary42023-10-012024-09-30140001677ns5:Subsidiary42023-10-012024-09-3014000167ns5:Subsidiary42024-09-3014000167ns5:Subsidiary42023-09-3014000167ns5:Subsidiary52023-10-012024-09-3014000167ns5:Subsidiary592023-10-012024-09-3014000167ns5:Subsidiary52024-09-3014000167ns5:Subsidiary52023-09-3014000167ns5:Subsidiary62023-10-012024-09-3014000167ns5:Subsidiary6112023-10-012024-09-3014000167ns5:Subsidiary62024-09-3014000167ns5:Subsidiary62023-09-3014000167ns10:OrdinaryShareClass12024-09-3014000167ns10:OrdinaryShareClass22024-09-3014000167ns10:OrdinaryShareClass32024-09-30
REGISTERED NUMBER: 14000167 (England and Wales)
















THE SUPERIOR HEALTHCARE GROUP HOLDINGS
LTD

STRATEGIC REPORT, REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2024






THE SUPERIOR HEALTHCARE GROUP HOLDINGS
LTD (REGISTERED NUMBER: 14000167)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024










Page

Company Information 1

Strategic Report 2

Report of the Directors 4

Report of the Independent Auditors 6

Income Statement 9

Other Comprehensive Income 10

Balance Sheet 11

Statement of Changes in Equity 12

Cash Flow Statement 13

Notes to the Cash Flow Statement 14

Notes to the Financial Statements 15


THE SUPERIOR HEALTHCARE GROUP HOLDINGS
LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2024







DIRECTORS: S Thorp
C Thorp
S Richards





REGISTERED OFFICE: 2 Lakeview Stables
Lower St. Clere
Kemsing
Sevenoaks
Kent
TN15 6NL





REGISTERED NUMBER: 14000167 (England and Wales)





AUDITORS: Lakeview Southern Audit Limited
Chartered Accountants and
Statutory Auditors
2 Lakeview Stables
Lower St. Clere
Kemsing
Sevenoaks
Kent
TN15 6NL

THE SUPERIOR HEALTHCARE GROUP HOLDINGS
LTD (REGISTERED NUMBER: 14000167)

STRATEGIC REPORT
FOR THE YEAR ENDED 30 SEPTEMBER 2024


The directors present their strategic report for the year ended 30 September 2024.

FAIR REVIEW OF BUSINESS
The Superior Healthcare Group Holdings Ltd is the holding company for The Superior Healthcare Group Ltd, Superior Nursing Services Ltd, Superior Complex Care Ltd, Superior Specialist Care Ltd and Superior Payroll Ltd ("The Superior Companies").

The principal activity of the Group's holdings is the provision of specialist, nurse-led care that supports people who have complex, long term health conditions to live safely at home. These services are delivered via The Superior Healthcare Group Ltd and Superior Nursing Services Ltd. Superior Payroll Ltd provided payroll services on behalf of the Group. Superior Complex Care Limited, Superior Specialist Care Limited and Superior Care Ltd were dormant throughout the period.

The Group continued to build upon its specialist care at home services, increasing hours of supply to more than 10,000 hours per week by 30th September 2024. The directors consider the performance of the Group to be satisfactory and believe that our businesses are well placed to grow again in the forthcoming year.

PRINCIPAL RISKS AND UNCERTAINTIES
The directors have identified that the business is exposed to the following risks:

Loss of registration
The Superior Healthcare Group Ltd's services are regulated by the Care Quality Commission and failure to comply with the CQC regulations could impact the Group's ability to provide our services. The directors seek to maintain compliance with the regulations through ongoing monitoring and internal assessment of compliance with statutory regulations. The current rating awarded to The Superior Healthcare Group Ltd by the Care Quality Commission is Good.

Loss of contract
The Group works extensively with NHS ICBs which continue to combine to create a smaller number of commissioning organisations. The directors seek to mitigate exposure to any single ICB through expansion of our geographic footprint and continued diversification of our client base.

Recruitment and employee retention
The Group's ability to deliver and grow its services depends upon the continued growth of our skilled team of carers and nurses. The Group invests heavily to both retain valued members of our team and to attract new employees to our businesses - not least by offering competitive rates of pay, prompt, regular and accurate payment of wages and an increasing range of employee benefits and wellbeing initiatives. Through its subsidiaries, the Group employs an in house team of trainers and clinical educators and offers funded diplomas and additional training opportunities to support employees to progress their careers.

Financial risk management
Credit risk - the principal credit risk arises from the Group's trade debtors. In order to manage credit risk, the Group reviews payment history, third party credit references, debt ageing and collection history on a regular basis.
Interest rate risk - the directors do not consider that the Group is materially exposed to the risk of interest rate rises.
Liquidity risk - the Group ensures that it has sufficient cash to meet the needs of the business through weekly cash forecasting and has effective, long-standing arrangements to support the working capital requirements of the business.

IT systems
The Group's operations depend upon a number of cloud-based IT systems. The directors ensure the security of our systems and data through the procurement of dedicated support contracts.


THE SUPERIOR HEALTHCARE GROUP HOLDINGS
LTD (REGISTERED NUMBER: 14000167)

STRATEGIC REPORT
FOR THE YEAR ENDED 30 SEPTEMBER 2024

KEY PERFORMANCE INDICATORS
The directors use a range of financial and non-financial key performance indicators to monitor the performance of the business and, in particular, monitors the following KPIs:

2024 2023 Change
Average number of care hours fulfilled weekly: 12,639 12,573 -%
Average weekly sales: £445,077 £404,574 + 10%
Average number of carers and nurses paid weekly: 455 445 + 2%
Average weekly working hours per carer and nurse: 28 28 -%

FUTURE DEVELOPMENTS
Since 30th September 2024, the Group continues to experience significant demand for our services. Our ability to fulfil the demands of our existing and prospective clients depends upon our ability to attract new people to the Group and to ensure a high rate of retention and engagement amongst our existing team. These continue to be our priorities for the year ahead.

The directors aim to continue to grow our businesses at a sustainable rate which ensures the quality of service that the people that we support rightly expect and to promote an environment in which our employees have the opportunity to thrive.

ON BEHALF OF THE BOARD:





S Thorp - Director


17 June 2025

THE SUPERIOR HEALTHCARE GROUP HOLDINGS
LTD (REGISTERED NUMBER: 14000167)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 30 SEPTEMBER 2024


The directors present their report with the financial statements of the company for the year ended 30 September 2024.

DIVIDENDS
The total distribution of dividends paid to Healthcare Investment Group Ltd the parent company for the year ended 30th September 2024 will be £1,700,000 (2023: £1,600,000).

DIRECTORS
The directors shown below have held office during the whole of the period from 1 October 2023 to the date of this report.

S Thorp
C Thorp
S Richards

EMPLOYEE ENGAGEMENT STATEMENT
Employee engagement is key to the Group's ability to attract and retain our employees and to the Group's overall success. The Group goes to significant lengths to provide a great working experience for colleagues including by providing an open and transparent working environment in which news and developments are shared. The Group provides structured as well as ad-hoc supervision sessions for employees and opportunities for our employees to develop their career prospects through providing access to ongoing training including apprenticeships. The Group has achieved significant successes through the promotion of longstanding employees; all career opportunities are advertised internally and promotions are celebrated by the business.

The Group employs a dedicated wellbeing team and provides all employees access to an employee assistance programme which includes providing access to counselling sessions where events in our employees' lives including homelives lead them to require extra support.

We fundamentally understand that our clients' wellbeing and the Group's success depends upon our people - and recognise our employees as our most valuable asset. To that end, the Group and directors are committed to finding opportunities to continually improve our employees' experience of working for us - and continue to evaluate our success in this area through regular employee surveys, supervision sessions and by providing other opportunities for employees to offer feedback and suggestions.

DISABLED PERSONS
Applications for employment by disabled persons will always be fully and proactively considered. In the event that employees become disabled, every effort is made to ensure that their employment within the Group continues and that appropriate support is offered and adjustments, made. It is the Group's policy that the training, career development and promotion of disabled people should, as far as possible, be identical to that of other employees.

MATTERS COVERED IN THE STRATEGIC REPORT
Information in respect of the business review, future developments, post balance sheet events, financial risk management and exposure to risks are not shown in the Directors' Report because they are presented in the Strategic Report in accordance with s414c(ii) of the Companies Act 2006.


THE SUPERIOR HEALTHCARE GROUP HOLDINGS
LTD (REGISTERED NUMBER: 14000167)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

DIRECTORS' RESPONSIBILITIES STATEMENT
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the Company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the Company's auditors are aware of that information.

AUDITORS
The auditors, Lakeview Southern Audit Limited, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





S Thorp - Director


17 June 2025

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
THE SUPERIOR HEALTHCARE GROUP HOLDINGS
LTD


Opinion
We have audited the financial statements of The Superior Healthcare Group Holdings Ltd (the 'company') for the year ended 30 September 2024 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 30 September 2024 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
THE SUPERIOR HEALTHCARE GROUP HOLDINGS
LTD


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Directors' Responsibilities Statement set out on page five, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We considered the central laws and regulations to the entity and identified those being of significance. We undertook an enquiry of management and those charged with governance to evaluate those of significance and any instances of non-compliance.

Through discussion and, where appropriate, written representation we obtained an understanding of the entity's policies and procedures in relation to fraud risks, including knowledge of any actual, suspected or alleged fraud.

The Senior Statutory Auditor has assessed that the engagement team collectively have the appropriate competence and capabilities to identify or recognise non-compliance with laws and regulations within the areas that they are responsible for testing.

Where necessary, documentation scrutiny was used to determine the significance of any instances with non-compliance of central laws and regulations and reviewed disclosures made in the financial statements to ensure these were appropriately made. We also reviewed the journals processed by the finance team and reviewed all transactions outside the normal course of the entity's business.

We communicated relevant identified laws and regulations and potential fraud risks to all engagement team members and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

Irregularities that result from fraud are inherently more difficult to detect from irregularities that result from error.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
THE SUPERIOR HEALTHCARE GROUP HOLDINGS
LTD


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Adrian Hull (Senior Statutory Auditor)
for and on behalf of Lakeview Southern Audit Limited
Chartered Accountants and
Statutory Auditors
2 Lakeview Stables
Lower St. Clere
Kemsing
Sevenoaks
Kent
TN15 6NL

17 June 2025

THE SUPERIOR HEALTHCARE GROUP HOLDINGS
LTD (REGISTERED NUMBER: 14000167)

INCOME STATEMENT
FOR THE YEAR ENDED 30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £   

TURNOVER - -
OPERATING PROFIT - -

Income from shares in group undertakings 1,700,000 1,600,000
PROFIT BEFORE TAXATION 1,700,000 1,600,000

Tax on profit 4 - -
PROFIT FOR THE FINANCIAL YEAR 1,700,000 1,600,000

THE SUPERIOR HEALTHCARE GROUP HOLDINGS
LTD (REGISTERED NUMBER: 14000167)

OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £   

PROFIT FOR THE YEAR 1,700,000 1,600,000


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

1,700,000

1,600,000

THE SUPERIOR HEALTHCARE GROUP HOLDINGS
LTD (REGISTERED NUMBER: 14000167)

BALANCE SHEET
30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £    £    £   
FIXED ASSETS
Investments 6 1,572 1,572

CURRENT ASSETS
Debtors 7 103 504,074
Cash at bank 229 332
332 504,406
CREDITORS
Amounts falling due within one year 8 695 504,769
NET CURRENT LIABILITIES (363 ) (363 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,209

1,209

CAPITAL AND RESERVES
Called up share capital 10 1,209 1,209
SHAREHOLDERS' FUNDS 1,209 1,209

The financial statements were approved by the Board of Directors and authorised for issue on 17 June 2025 and were signed on its behalf by:





S Thorp - Director


THE SUPERIOR HEALTHCARE GROUP HOLDINGS
LTD (REGISTERED NUMBER: 14000167)

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 SEPTEMBER 2024

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 October 2022 1,209 - 1,209

Changes in equity
Dividends - (1,600,000 ) (1,600,000 )
Total comprehensive income - 1,600,000 1,600,000
Balance at 30 September 2023 1,209 - 1,209

Changes in equity
Dividends - (1,700,000 ) (1,700,000 )
Total comprehensive income - 1,700,000 1,700,000
Balance at 30 September 2024 1,209 - 1,209

THE SUPERIOR HEALTHCARE GROUP HOLDINGS
LTD (REGISTERED NUMBER: 14000167)

CASH FLOW STATEMENT
FOR THE YEAR ENDED 30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 - -

Cash flows from investing activities
Purchase of fixed asset investments - (2 )
Dividends received 1,700,000 1,600,000
Net cash from investing activities 1,700,000 1,599,998

Cash flows from financing activities
Intercompany loan movements (103 ) 332
Amount introduced by directors - 2
Equity dividends paid (1,700,000 ) (1,600,000 )
Net cash from financing activities (1,700,103 ) (1,599,666 )

(Decrease)/increase in cash and cash equivalents (103 ) 332
Cash and cash equivalents at beginning of
year

2

332

-

Cash and cash equivalents at end of year 2 229 332

THE SUPERIOR HEALTHCARE GROUP HOLDINGS
LTD (REGISTERED NUMBER: 14000167)

NOTES TO THE CASH FLOW STATEMENT
FOR THE YEAR ENDED 30 SEPTEMBER 2024


1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM
OPERATIONS

30.9.24 30.9.23
£    £   
Profit before taxation 1,700,000 1,600,000
Finance income (1,700,000 ) (1,600,000 )
Cash generated from operations - -

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 30 September 2024
30.9.24 1.10.23
£    £   
Cash and cash equivalents 229 332
Year ended 30 September 2023
30.9.23 1.10.22
£    £   
Cash and cash equivalents 332 -


3. ANALYSIS OF CHANGES IN NET FUNDS

At 1.10.23 Cash flow At 30.9.24
£    £    £   
Net cash
Cash at bank 332 (103 ) 229
332 (103 ) 229
Total 332 (103 ) 229

THE SUPERIOR HEALTHCARE GROUP HOLDINGS
LTD (REGISTERED NUMBER: 14000167)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024


1. STATUTORY INFORMATION

The Superior Healthcare Group Holdings Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Preparation of consolidated financial statements
The financial statements contain information about The Superior Healthcare Group Holdings Ltd as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 400 of the Companies Act 2006 from the requirements to prepare consolidated financial statements as it and its subsidiary undertakings are included by full consolidation in the consolidated financial statements of its parent, Healthcare Investment Group Limited, 2 Lakeview Stables, Lower St. Clere, Kemsing, Sevenoaks, Kent, TN15 6NL.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classified as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains and losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


THE SUPERIOR HEALTHCARE GROUP HOLDINGS
LTD (REGISTERED NUMBER: 14000167)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

There were no staff costs for the year ended 30 September 2024 nor for the year ended 30 September 2023.

The average number of employees during the year was as follows:
30.9.24 30.9.23

Directors 3 3

30.9.24 30.9.23
£    £   
Directors' remuneration - -

4. TAXATION

Analysis of the tax charge
No liability to UK corporation tax arose for the year ended 30 September 2024 nor for the year ended 30 September 2023.

5. DIVIDENDS
30.9.24 30.9.23
£    £   
Ordinary A shares of £1 each
Interim 1,700,000 1,600,000

6. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 October 2023
and 30 September 2024 1,572
NET BOOK VALUE
At 30 September 2024 1,572
At 30 September 2023 1,572

THE SUPERIOR HEALTHCARE GROUP HOLDINGS
LTD (REGISTERED NUMBER: 14000167)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


6. FIXED ASSET INVESTMENTS - continued

The company's investments at the Balance Sheet date in the share capital of companies include the following:

The Superior Healthcare Group Ltd
Registered office: Gazette House 5-8 Estuary View Business Park, Boorman Way, Whitstable, Kent, England, CT5 3SE
Nature of business: Nursing Services
%
Class of shares: holding
Ordinary 100.00
30.9.24 30.9.23
£    £   
Aggregate capital and reserves 615,732 583,793
Profit for the year 2,221,745 921,310

Superior Nursing Services Ltd
Registered office: 2 Lakeview Stables, Lower St. Clere, Kemsing, Sevenoaks, Kent, England, TN15 6NL
Nature of business: Nursing Services
%
Class of shares: holding
Ordinary 100.00
30.9.24 30.9.23
£    £   
Aggregate capital and reserves 138,937 35,194
Profit for the year 205,887 1,427,352

Superior Payroll Ltd
Registered office: 2 Lakeview Stables, Lower St. Clere, Kemsing, Sevenoaks, Kent, England, TN15 6NL
Nature of business: Payroll services
%
Class of shares: holding
Ordinary 100.00
30.9.24 30.9.23
£    £   
Aggregate capital and reserves 120 120

Superior Complex Care Limited
Registered office: 2 Lakeview Stables, Lower St. Clere, Kemsing, Sevenoaks, Kent, England, TN15 6NL
Nature of business: Dormant Company
%
Class of shares: holding
Ordinary 100.00
30.9.24 30.9.23
£    £   
Aggregate capital and reserves 1 1

THE SUPERIOR HEALTHCARE GROUP HOLDINGS
LTD (REGISTERED NUMBER: 14000167)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


6. FIXED ASSET INVESTMENTS - continued

Superior Specialist Care Limited
Registered office: 2 Lakeview Stables, Lower St. Clere, Kemsing, Sevenoaks, Kent, England, TN15 6NL
Nature of business: Dormant Company
%
Class of shares: holding
Ordinary 100.00
30.9.24 30.9.23
£    £   
Aggregate capital and reserves 120 120

Superior Care Limited
Registered office: 2 Lakeview Stables,Lower St.Clere, Kemsing, Sevenoaks, Kent, England, TN15 6NL
Nature of business: Other human health activities
%
Class of shares: holding
Ordinary 100.00
30.9.24 30.9.23
£    £   
Aggregate capital and reserves 2 2

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Amounts owed by group undertakings 103 504,074

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Amounts owed to group undertakings 693 504,767
Directors' current accounts 2 2
695 504,769

9. FINANCIAL INSTRUMENTS

The company has basic financial debt instruments which are all measured at cost. These include other debtors, cash at bank and other creditors.

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.9.24 30.9.23
value: £    £   
1,200 Ordinary A £1 1,200 1,200
1 Ordinary B £1 1 1
8 Ordinary C £1 8 8
1,209 1,209

THE SUPERIOR HEALTHCARE GROUP HOLDINGS
LTD (REGISTERED NUMBER: 14000167)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


10. CALLED UP SHARE CAPITAL - continued

The ordinary A shares have voting rights, an entitlement to dividends and an entitlement to distribution on liquidation or sale.

The ordinary B shares hold no voting rights, have an entitlement to dividends, and will have no rights over surplus assets or proceeds should the company be liquidated or sold.

The ordinary C shares hold no voting rights, have an entitlement to dividends, and will have no rights over surplus assets or proceeds should the company be liquidated or sold.

11. RESERVES
Retained
earnings
£   

Profit for the year 1,700,000
Dividends (1,700,000 )
At 30 September 2024 -

The retained earnings is the cumulative profit and loss net of distributions.

12. RELATED PARTY DISCLOSURES

The company owed £Nil (2023: £504,647) to its parent Healthcare Investment Group Ltd, and £693 (2023: £120) to its subsidiary Superior Payroll Ltd at 30th September 2024.

The company was owed £Nil (2023: £218,000) by Superior Nursing Services Ltd and £103 (2023: £286,074) from its subsidiary The Superior Healthcare Group Ltd at 30th September 2024.

13. PRINCIPLE PLACE OF BUSINESS

The company's principal place of business is Gazette House, 5-8 Estuary View Business Park, Boorman Way, Whitstable, Kent, CT5 3SE.

14. ULTIMATE PARENT ENTITY

Healthcare Investment Group Ltd is regarded by the directors as being the company's ultimate parent company.

Company Number: 13577568
Registered Office: 2 Lakeview Stables, Lower St. Clere, Kemsing, Sevenoaks, Kent, England, TN15 6NL.
Principal place of business : Gazette House 5-8 Estuary View Business Park, Boorman Way, Whitstable, Kent, England, CT5 3SE.

The Superior Healthcare Group Holdings Ltd holds the entire issued share capital of The Superior Healthcare Group Ltd, Superior Nursing Services Ltd, Superior Complex Care Ltd, Superior Specialist Care Ltd and Superior Payroll Ltd. In the year the entire issued share capital of Superior Care Ltd was purchased by The Superior Healthcare Group Holdings Ltd.

15. ULTIMATE CONTROLLING PARTY

The ultimate controlling parties are S Thorp and C Thorp.